Amphera's MesoPher Cell Therapy Demonstrates Favourable Safety and Promising Survival in a Phase II Clinical Trial in Resected Pancreatic Cancer
Positive results from first cohort of 10 patients from REACtiVe study published in European Journal of Cancer Amphera B.V. announces positive REACtiVe Phase 2 study safety and efficacy data from the
Source: finanznachrichten.de